A multicentre, Parallel Group Open-label RC Non-Inferiority Trial of piperacillin-tazobactam versus meropenem for definitive treatment of bloodstream infection due to AmpC-producing Enterobacterales (2018–2021)
- Grant type:
- Junior Doctor Research Fellowships
- Researchers:
-
-
- Funded by:
- Queensland Health
